new catalyst on 4 th of june, FDA approval on ryplazim. this stock has been very weak for a while now. big movement imminent on monday
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
